Cargando…
Assessment of the reporting quality of randomized controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: a systematic review
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733238/ https://www.ncbi.nlm.nih.gov/pubmed/34999174 http://dx.doi.org/10.1016/j.cmi.2021.12.016 |
| _version_ | 1784627758301708288 |
|---|---|
| author | Jung, Youn-Joo Oh, Yunkyoung Purja, Sujata Jeong, Hyokeun Kim, EunYoung |
| author_facet | Jung, Youn-Joo Oh, Yunkyoung Purja, Sujata Jeong, Hyokeun Kim, EunYoung |
| author_sort | Jung, Youn-Joo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8733238 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87332382022-01-06 Assessment of the reporting quality of randomized controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: a systematic review Jung, Youn-Joo Oh, Yunkyoung Purja, Sujata Jeong, Hyokeun Kim, EunYoung Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-04 2022-01-06 /pmc/articles/PMC8733238/ /pubmed/34999174 http://dx.doi.org/10.1016/j.cmi.2021.12.016 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Jung, Youn-Joo Oh, Yunkyoung Purja, Sujata Jeong, Hyokeun Kim, EunYoung Assessment of the reporting quality of randomized controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: a systematic review |
| title | Assessment of the reporting quality of randomized controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: a systematic review |
| title_full | Assessment of the reporting quality of randomized controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: a systematic review |
| title_fullStr | Assessment of the reporting quality of randomized controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: a systematic review |
| title_full_unstemmed | Assessment of the reporting quality of randomized controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: a systematic review |
| title_short | Assessment of the reporting quality of randomized controlled trials related to the pharmacotherapy of COVID-19 based on the CONSORT 2010 checklist: a systematic review |
| title_sort | assessment of the reporting quality of randomized controlled trials related to the pharmacotherapy of covid-19 based on the consort 2010 checklist: a systematic review |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733238/ https://www.ncbi.nlm.nih.gov/pubmed/34999174 http://dx.doi.org/10.1016/j.cmi.2021.12.016 |
| work_keys_str_mv | AT jungyounjoo assessmentofthereportingqualityofrandomizedcontrolledtrialsrelatedtothepharmacotherapyofcovid19basedontheconsort2010checklistasystematicreview AT ohyunkyoung assessmentofthereportingqualityofrandomizedcontrolledtrialsrelatedtothepharmacotherapyofcovid19basedontheconsort2010checklistasystematicreview AT purjasujata assessmentofthereportingqualityofrandomizedcontrolledtrialsrelatedtothepharmacotherapyofcovid19basedontheconsort2010checklistasystematicreview AT jeonghyokeun assessmentofthereportingqualityofrandomizedcontrolledtrialsrelatedtothepharmacotherapyofcovid19basedontheconsort2010checklistasystematicreview AT kimeunyoung assessmentofthereportingqualityofrandomizedcontrolledtrialsrelatedtothepharmacotherapyofcovid19basedontheconsort2010checklistasystematicreview |